News
Ahituv selected for American Society of Human Genetics Scientific Achievement Award
The director of the UCSF Institute for Human Genetics (IHG) is being recognized for his lab’s work investigating gene regulatory elements––their relationship to human diversity and disease and their utilization for gene therapy.
School of Pharmacy celebrates global drug development and regulatory science collaboration
June 14, 2024, marked the 15-year collaboration of a Chinese course improving medical product development and regulation.
Benet honored in symposium with endowed professorship
The pioneering career of one of the School’s most influential faculty members was honored on his 87th birthday.
Savic receives NIH funding to establish tuberculosis consortium
Despite being preventable and curable, tuberculosis remains the world’s leading infectious disease killer. According to the World Health Organization, an estimated 10.6 million people became ill with tuberculosis and 1.3 million died from the disease in 2022 alone.
Savic receives NIH funding to establish tuberculosis consortium
The Preclinical Design and Clinical Translation of TB Regimens (PReDicTR) Consortium has been awarded a $30.8M grant over five years to research the most effective treatment options for future clinical testing.
School of Pharmacy leads in NIH funding for the 44th straight year
School researchers netted $36.7M from 65 grants, fueling efforts spanning drug discovery, bioengineering, pharmacokinetics, clinical pharmacy, and more.
Sali to deliver UCSF Academic Senate’s 66th Annual Faculty Research Lecture in Basic Science
A leader in computational biology and integrative structure modeling, Andrej Sali, PhD, was selected by the UCSF Academic Senate to give the Annual Faculty Research Lectureship in Basic Science.
Sali to deliver UCSF Academic Senate’s 66th Annual Faculty Research Lecture in Basic Science
Attend in person at Mission Bay or on Zoom at 3:30 p.m. Pacific on Tuesday, April 16. Reception to follow.
School introduces new Master of Science program in AI and Computational Drug Discovery and Development
The first program of its kind in the United States, the MS in AICD3 will enable its graduates to gain a competitive edge for some of the most desirable jobs in the biopharmaceutical industry and in academia.
Guo named inaugural director of new Center for Collaborative Innovation
Su Guo, PhD, will lead a new center to increase collaboration between clinical, translational, and discovery science in teaching and research.
PharmD program creates new opportunities to explore industry and research career paths
Students keep pace with latest innovations through experiential options and advanced degrees.
Kortemme named new vice dean of research
Computational biology and protein engineering expert will focus on cultivating collaboration.
QBI and Director Krogan’s COVID and infectious disease efforts continue to make waves
QBI publishes breakthrough on COVID-19 variants; Nevan Krogan recognized as trailblazer.
Update from the Dean: Putting plans in action
Dean Kathy Giacomini shares how the School’s recent breakthroughs and accomplishments are bringing our new strategic plan to life.
The Kidney Project proves its bioreactor can keep kidney cells alive for at least one week
Scientists have shown for the first time that kidney cells—housed in an implantable device called a bioreactor—can survive while implanted.
A budding partnership with Korean regulatory science pharmacists
A delegation from South Korea visited to sign a Memorandum of Understand (MOU) initiating potential collaborations between UCSF and Korean schools of pharmacy.
Innovation gets a boost from 2023 Koda-Kimble Seed Awards
This ninth year of awards focuses on research advancing health and furthering understanding related to cancer, diabetes, HIV testing, immune response, and more.